Granules India Limited has reported robust financial results for the fiscal year ended March 31, 2026. The company achieved consolidated revenue of ₹53,656.42 million and a profit after tax of ₹5,950.21 million. Driven by strategic growth, including the acquisition of Senn Chemicals AG and new international expansion, the company continues to demonstrate resilience and strong operational performance in the global pharmaceutical market.
Financial Highlights for FY26
Granules India reported significant financial growth for the year ended March 31, 2026. Consolidated annual revenue reached ₹53,656.42 million, compared to ₹44,816.08 million in the previous fiscal year. The company’s annual profit after tax stood at ₹5,950.21 million, up from ₹5,015.16 million in FY25. For the final quarter (Q4: Jan-Mar 2026), the company recorded a consolidated revenue of ₹14,706.08 million and a profit of ₹2,015.68 million.
Strategic Acquisitions and Expansion
During the fiscal year, Granules India focused on strengthening its global footprint. A key milestone was the acquisition of Senn Chemicals AG, which became a wholly-owned subsidiary effective April 10, 2025. Additionally, the company acquired a 100% equity stake in Granules Pharmaceuticals GmbH in Germany in November 2025 and incorporated Granules Pharmaceuticals Canada, Inc. to further enhance its market reach.
Operational Resilience
Despite regulatory challenges at the Gagillapur facility, which necessitated a temporary voluntary pause in operations to address quality observations, the company successfully implemented comprehensive remedial measures. These steps involved engaging independent consultants to upgrade internal procedures and data integrity, ensuring compliance with international standards.
Dividend and Future Outlook
Reflecting confidence in the company’s financial position and growth trajectory, the Board of Directors has recommended a final dividend of ₹1.75 per equity share. Furthermore, the company continues to progress with its preferential issuance of warrants, having already received ₹3,656.25 million as the initial 25% payment, signaling strong investor support for future expansion plans.
Source: BSE
